23 Jul, 2026
According to Straits Research, the global sequencing consumables market size was valued at $10.25 billion in 2025 and is estimated to reach $62.90 billion by 2034, growing at a CAGR of 22.37% during the forecast period 2026–2034.
The global sequencing consumables market is experiencing substantial growth, primarily driven by the increasing adoption of next-generation sequencing technologies across research and clinical settings. NGS allows for high-throughput analysis of genetic material, enabling rapid and accurate genomic profiling, which is essential for applications such as precision medicine, disease diagnostics, and biomarker discovery. The rising prevalence of genetic disorders, cancer, and infectious diseases is further propelling the demand for sequencing consumables, as researchers and clinicians increasingly rely on these tools to understand disease mechanisms, develop targeted therapies, and improve patient outcomes. Additionally, government initiatives and funding to support genomics research are contributing to market expansion in developed regions.
However, the market faces restraints due to the high cost of sequencing consumables and reagents, which limit adoption in smaller laboratories and emerging economies. The need for specialized infrastructure, skilled personnel, and a regular supply of high-quality consumables adds to the operational expenses, creating challenges for widespread utilization. On the other hand, the growing trend of personalized medicine presents a notable opportunity for the sequencing consumables market. As healthcare increasingly shifts toward individualized treatment plans based on genetic profiling, demand for scalable and cost-effective sequencing consumables is expected to rise.
sales@straitsresearch.com